- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 11441
Historique des publications depuis 10 ans
|
315
|
474
|
639
|
846
|
926
|
1044
|
1200
|
1105
|
1211
|
805
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1156 |
686 |
| Iovance Biotherapeutics, Inc. | 339 |
252 |
| The Regents of the University of California | 19961 |
225 |
| The Trustees of the University of Pennsylvania | 4323 |
205 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2855 |
149 |
| Board of Regents, The University of Texas System | 5808 |
143 |
| Cellectis | 403 |
129 |
| Juno Therapeutics, Inc. | 414 |
114 |
| Memorial Sloan-Kettering Cancer Center | 1931 |
113 |
| Baylor College of Medicine | 950 |
104 |
| Novartis AG | 10744 |
98 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
98 |
| City of Hope | 994 |
87 |
| Immunitybio, Inc. | 378 |
85 |
| Autolus Limited | 252 |
83 |
| Kite Pharma, Inc. | 414 |
78 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 950 |
76 |
| Regents of the University of Minnesota | 2693 |
73 |
| FATE Therapeutics, Inc. | 206 |
70 |
| Kyoto University | 2801 |
64 |
| Autres propriétaires | 8509 |